Atlas market file · Equity · Europe
Valerio TherapeuticsALVIO
- Last close
- 0.749
- Change
- -0.13%
- 96-bar range
- 0.1025 – 0.98
- As of
- 30 Jul 2026
Valerio Therapeutics is a healthcare or life-sciences issuer listed as ALVIO on EURONEXT. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- EURONEXT symbol identity
- Chart rail
- TradingView
- File state
- Public profile
ALVIO
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
â–® up candle â–® down candle
Weekly outlook: the last 104 weekly closes (+771.76% over the window).
Source rail: Yahoo Finance chart API (ALVIO.PA). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for ALVIO. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
ALVIO public profile
Healthcare or life-sciences issuer. Valerio Therapeutics is connected to current market context, cited company sources and its retained research file.
Valerio Therapeutics trades as ALVIO on EURONEXT. Valerio Therapeutics (ALVIO) has a latest verified close of 0.749, down 0.13%, dated 30 Jul 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ALVIO under Healthcare & Medicine Stocks for browsing.
Market Wit preview
Valerio Therapeutics has the awkward job of being more than ALVIO, which is not always how markets behave. Valerio Therapeutics is listed on EURONEXT in Europe with TradingView symbol EURONEXT:ALVIO and public listing evidence. A ticker can reduce a whole business to a blinking square, but customers, products, margins, suppliers, regulation, capital, and cash still have to do the actual work. Until fresh operating data arrives, ALVIO is best read through customers, margins, capital and disclosure rather than the daily price, because the business is the part that survives after the quote has moved on (source: public profile, https://atlas.freedomcore.io/stocks/ALVIO/).
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for ALVIO.
What changed for Valerio Therapeutics today
Valerio Therapeutics (ALVIO) is tracked as a listed company on EURONEXT. The public profile anchors the symbol identity, region, chart route, and research-only context for the Europe market before any daily source layer is added.
ALVIO is handled first as a equity file: identity, listing route, source trail, chart context, and the current limits of the public evidence set.
The deeper daily research layer expands only when fresh evidence changes the file. Until then, this page keeps the public profile, chart route, risks, catalysts, and research-only framing explicit instead of manufacturing movement for its own sake.
Sources & evidence · 1 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
ALVIO technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-27. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on ALVIO
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep ALVIO research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
ALVIO FAQ
What is Valerio Therapeutics (ALVIO)?Valerio Therapeutics (ALVIO) has a latest verified close of 0.749, down 0.13%, dated 30 Jul 2026. Use this page to check the price chart, company context, source-backed...
Valerio Therapeutics (ALVIO) has a latest verified close of 0.749, down 0.13%, dated 30 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for ALVIO?Valerio Therapeutics (ALVIO) has a latest verified close of 0.749, down 0.13%, dated 30 Jul 2026. It brings the latest available chart, company context, cited sources,...
Valerio Therapeutics (ALVIO) has a latest verified close of 0.749, down 0.13%, dated 30 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ALVIO under Healthcare & Medicine Stocks for browsing.
How often is the ALVIO page updated?The ALVIO public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The ALVIO public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for ALVIO?The ALVIO file starts with EURONEXT symbol identity and TradingView EURONEXT:ALVIO. The page separates verified market context from company evidence and shows open...
The ALVIO file starts with EURONEXT symbol identity and TradingView EURONEXT:ALVIO. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on ALVIO?Yes. The workstation can open ALVIO, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open ALVIO, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this ALVIO page investment advice?No. The ALVIO page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The ALVIO page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-07-30. Browse FreedomCore Atlas research notes →